| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Kamada Ltd (NASDAQ: KMDA)
KMDA Technical Analysis
2
| As on 9th Jun 2023 KMDA STOCK Price closed @ 5.33 and we RECOMMEND Buy for LONG-TERM with Stoploss of 5.19 & Strong Sell for SHORT-TERM with Stoploss of 6.19 we also expect STOCK to react on Following IMPORTANT LEVELS. |
KMDASTOCK Price
| Open | 5.15 | Change | Price | % |
| High | 5.35 | 1 Day | 0.18 | 3.50 |
| Low | 5.15 | 1 Week | 0.50 | 10.35 |
| Close | 5.33 | 1 Month | 0.80 | 17.66 |
| Volume | 23300 | 1 Year | -1.30 | -19.61 |
| 52 Week High 6.82 | 52 Week Low 3.79 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| KMDA Daily Charts |
KMDA Intraday Charts |
Whats New @ Bazaartrend |
KMDA Free Analysis |
|
|
KMDA Important Levels Intraday
| RESISTANCE | 5.72 |
| RESISTANCE | 5.59 |
| RESISTANCE | 5.52 |
| RESISTANCE | 5.44 |
| SUPPORT | 5.22 |
| SUPPORT | 5.14 |
| SUPPORT | 5.07 |
| SUPPORT | 4.94 |
KMDA Forecast May 2024
| 4th UP Forecast | 7.35 |
| 3rd UP Forecast | 6.7 |
| 2nd UP Forecast | 6.3 |
| 1st UP Forecast | 5.9 |
| 1st DOWN Forecast | 4.76 |
| 2nd DOWN Forecast | 4.36 |
| 3rd DOWN Forecast | 3.96 |
| 4th DOWN Forecast | 3.31 |
KMDA Weekly Forecast
| 4th UP Forecast | 6.39 |
| 3rd UP Forecast | 6.05 |
| 2nd UP Forecast | 5.84 |
| 1st UP Forecast | 5.63 |
| 1st DOWN Forecast | 5.03 |
| 2nd DOWN Forecast | 4.82 |
| 3rd DOWN Forecast | 4.61 |
| 4th DOWN Forecast | 4.27 |
KMDA Forecast2024
| 4th UP Forecast | 11.57 |
| 3rd UP Forecast | 9.57 |
| 2nd UP Forecast | 8.33 |
| 1st UP Forecast | 7.1 |
| 1st DOWN Forecast | 3.56 |
| 2nd DOWN Forecast | 2.33 |
| 3rd DOWN Forecast | 1.09 |
| 4th DOWN Forecast | -0.91 |
Kamada Ltd ( NASDAQ USA Symbol : KMDA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
KMDA Business Profile
Kamada Ltd. develops, produces, and markets plasma-derived protein therapeutics for orphan indications. It operates in two segments, Proprietary Products and Distribution. The company offers Glassia for use in chronic augmentation and maintenance therapy in adults with emphysema due to congenital Alpha-1 Antitrypsin (AAT) deficiency. It also provides KamRAB for prophylaxis of rabies disease; KamRho (D) IM to treat prophylaxis of hemolytic disease of newborns; KamRho (D) IV for immune thermobocytopunic purpura; and snake bite antiserum to treat snake bites by the vipera palaestinae and echis coloratus. In addition, the company distributes Bramitob to manage chronic pulmonary infection; FOSTER to treat asthma; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; IVIG 5% for the treatment of various immunodeficiency-related conditions; AeroBika, an OPEP device; Varitect, a varicella zoster immunoglobulin; Zutectra and Hepatect CP for the prevention of hepatitis B virus; Megalotect, a CMV immunoglobulin; and RUCONEST for the treatment of acute angioedema attacks in adults with hereditary angioedema. Further, it distributes Heparin sodium injection to treat thrombo-embolic disorders; Albumin and Albumin 4% for maintenance of blood plasma; and coagulation factors comprising Factor VIII and Factor IX, as well as IXIARO vaccine. It markets its products through strategic partners in the United States, as well as through distributors internationally. Kamada Ltd. has strategic partnerships with Takeda Pharmaceutical Company Limited; PARI GmbH; and Kedrion Biopharma. The company was incorporated in 1990 and is headquartered in Rehovot, Israel. Address: 2 Holzman Street, Rehovot, Israel, 7670402
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service